Publications by authors named "Charles Randall"

Claim this Profile
A
A Novel, IBS-Specific IgG ELISA-Based Elimination Diet in Irritable Bowel Syndrome: A Randomized, Sham-Controlled Trial.
Prashant Singh, William D Chey, Will Takakura, Brooks D Cash, Brian E Lacy, Charles W Randall

Gastroenterology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease.
Matthieu Allez, Bruce E Sands, Brian G Feagan, Geert D'Haens, Gert De Hertogh, Charles W Randall

J Crohns Colitis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease.
William J Sandborn, Bal R Bhandari, Charles Randall, Ziad H Younes, Tomasz Romanczyk

J Crohns Colitis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned.
Anita Afzali, Matthew A Ciorba, David A Schwartz, Mai Sharaf, Chris Fourment, Charles W Randall

Inflamm Bowel Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials.
Edward V Loftus, Jean-Frederic Colombel, Stefan Schreiber, Charles W Randall, Miguel Regueiro

Clin Gastroenterol Hepatol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
Scott D Lee, David T Rubin, William J Sandborn, Charles Randall, Ziad Younes

Inflamm Bowel Dis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's disease.
Charles W Randall, John A Vizuete, Nicholas Martinez, John J Alvarez, Karthik V Garapati

Therap Adv Gastroenterol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Leonard S Dove, Anthony Lembo, Charles W Randall, Ronald Fogel, David Andrae

Gastroenterology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and emerging strategies in the management of Crohn's disease.
Charles Randall, John Vizuete, Gregg Wendorf, Balaji Ayyar, Gregory Constantine

Best Pract Res Clin Gastroenterol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis